Christopher H. B. Mills Sells 83,696 Shares of Renalytix Plc (LON:RENX) Stock

Renalytix Plc (LON:RENX) insider Christopher H. B. Mills sold 83,696 shares of the firm’s stock in a transaction that occurred on Monday, October 7th. The stock was sold at an average price of GBX 8 ($0.10), for a total value of £6,695.68 ($8,762.83).

Renalytix Price Performance

Shares of RENX stock opened at GBX 7.50 ($0.10) on Friday. Renalytix Plc has a 52-week low of GBX 7 ($0.09) and a 52-week high of GBX 74.90 ($0.98). The company has a debt-to-equity ratio of 173.95, a quick ratio of 2.42 and a current ratio of 0.53. The firm has a market capitalization of £12.44 million, a P/E ratio of -32.38 and a beta of 2.10. The stock has a 50 day moving average price of GBX 10.79 and a 200 day moving average price of GBX 17.35.

About Renalytix

Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics, and personalized patient data from electronic health record systems to generate a unique patient risk score.